Equity · KR Market · Earnings Season

K200 실적 시즌 — 2026년 3분기 잠정실적KOSPI 200 earnings season — Q3 2026 preliminary resultsKOSPI200決算シーズン — 2026年第3四半期の速報値

분기보고서가 나오기 전, 회사들이 먼저 발표하는 잠정실적을 한 자리에 모았다. 누가 언제 발표했는지, 발표한 회사들의 영업이익과 순이익이 전년·전분기보다 얼마나 달라졌는지, 어느 업종이 늘고 줄었는지를 본다. 합계는 가장 큰 두 회사와 지주회사를 뺀 값도 같이 적는다. 밸류에이션은 P/B 를 기준으로 본다 — 역대 P/B 밴드 안에서 지금의 자리, 그리고 P/B 와 P/E 의 차이(이익이 평소보다 얼마나 많은가).This page gathers in one place the preliminary results that companies announce before their quarterly reports come out. It shows who announced and when, how much the operating profit and net profit of the companies that announced changed from a year earlier and from the previous quarter, and which sectors rose and fell. The sums are also given excluding the two largest companies and the holding companies. Valuation is viewed with P/B as the yardstick — where P/B now sits within its historical band, and the gap between P/B and P/E (how far earnings are above their usual level).四半期報告書が出る前に企業が先に発表する速報値(暫定決算)を一か所に集めた。誰がいつ発表したか、発表企業の営業利益と純利益が前年・前四半期からどれだけ変わったか、どの業種が増えて減ったかを見る。合計は最大2社と持株会社を除いた値も併記する。バリュエーションはPBRを基準に見る — 過去のPBRバンドの中での現在の位置、そしてPBRとPERの差(利益が平常よりどれだけ多いか)。

2026년 3분기Q3 20262026年第3四半期발표 199곳 / 199종목199 announced / 199 stocks発表199社 / 199銘柄마지막 접수 2026-11-11Last filing 2026-11-11最終受付:2026-11-11
먼저 보는 세 줄 · 2026-11-11Three lines first · 2026-11-11まず見る三行 · 2026-11-11
  1. K200 199종목 가운데 199곳이 2026년 3분기 실적을 발표했다(분기보고서 199곳). 발표한 회사의 영업이익 합계는 240.2조 — 전년비 +291.1%, 가장 큰 두 곳을 빼면 +30.5%, 지주회사까지 빼면 +19.4%. 영업이익이 늘어난 회사 102곳 · 줄어든 회사 43곳.Of the 199 KOSPI 200 stocks, 199 have announced Q3 2026 results (199 quarterly reports). Operating profit of the companies that announced totals KRW 240.2trn — +291.1% YoY, +30.5% excluding the two largest and +19.4% also excluding holding companies. Operating profit rose at 102 companies and fell at 43.KOSPI200の199銘柄のうち199社が2026年第3四半期の実績を発表した(四半期報告書199社)。発表企業の営業利益合計は240.2兆ウォン — 前年同期比+291.1%、最大2社を除くと+30.5%、持株会社も除くと+19.4%。営業利益が増えた企業102社 · 減った企業43社。
  2. 밸류에이션의 기준은 P/B 다. 2013년부터 자료가 있는 같은 109사의 P/B 는 1.69배(역대 연말 0.80~1.48배) — 평소 대비 +42 가운데 P/E 쪽 -77 · ROE 쪽 +119. ROE 24.9% 는 평소의 3.3배다.P/B is the yardstick for valuation. P/B of the same 109 companies with data since 2013 is 1.69x (year-ends on record 0.80–1.48x) — of the +42 against its usual level, the P/E part is -77 and the ROE part +119. ROE of 24.9% is 3.3 times its usual level.バリュエーションの基準はPBRである。2013年からデータがある同じ109社のPBRは1.69倍(過去の年末0.80~1.48倍) — 平常値比+42のうちPER要因-77 · ROE要因+119。ROE 24.9%は平常値の3.3倍である。
K200 발표KOSPI 200 announcedKOSPI200 発表
199곳companies社
199종목 가운데 · 분기보고서 199곳out of 199 stocks · 199 quarterly reports199銘柄のうち · 四半期報告書199社
영업이익 합계Operating profit, total営業利益合計
240.2조KRW trn兆ウォン
전년비 +291% · 전분기비 +16%YoY +291% · QoQ +16%前年同期比+291% · 前期比+16%
가장 큰 두 곳 제외Excluding the two largest最大2社を除く
+30.5%
영업이익 49.4조 · 순이익 전년비 -0.7%operating profit KRW 49.4trn · net profit YoY -0.7%営業利益49.4兆ウォン · 純利益の前年同期比-0.7%
영업이익 증가 / 감소Operating profit up / down営業利益 増加 / 減少
102 / 43곳companies社
영업적자 9곳operating loss 9営業赤字9社
P/B (같은 109사)P/B (same 109 companies)PBR(同じ109社)
1.69배x倍
역대 연말 0.80~1.48 · 가운데 1.11year-ends on record 0.80–1.48 · median 1.11過去の年末0.80~1.48 · 中央値1.11
P/B 와 P/E 의 차이 = ROEGap between P/B and P/E = ROEPBRとPERの差 = ROE
24.9%
평소 7.6% · 잠정 반영 24.9%usual 7.6% · with preliminary results 24.9%平常値7.6% · 速報値反映24.9%
숫자는 각 회사의 영업(잠정)실적 공정공시에서 옮겼다. 공시에 적힌 전년동기·전분기 값이 그 회사의 정기보고서 값과 맞는 연결 기준 공시만 합계에 넣었다. 한 회사가 여러 번 공시했으면 그 분기 전체를 덮는 가장 최근 공시를 쓴다.Figures are taken from each company's fair-disclosure announcement of preliminary operating results. Only consolidated-basis announcements whose year-earlier and previous-quarter figures match the company's periodic-report values are included in the sums. Where a company announced several times, the most recent announcement covering the whole quarter is used.数値は各社の営業(暫定)実績の公正開示から転記した。開示に記載された前年同期・前四半期の値がその企業の定期報告書の値と一致する連結ベースの開示のみを合計に含めた。一社が複数回開示した場合は、その四半期全体をカバーする最新の開示を使う。
00

한 줄In one line一行で

K200 199종목 가운데 199곳이 2026년 3분기 실적을 발표했다(분기보고서 199곳). 발표한 회사의 영업이익 합계는 240.2조 — 전년비 +291.1%, 가장 큰 두 곳을 빼면 +30.5%, 지주회사까지 빼면 +19.4%. 영업이익이 늘어난 회사 102곳 · 줄어든 회사 43곳. 밸류에이션의 기준은 P/B 다. 2013년부터 자료가 있는 같은 109사의 P/B 는 1.69배(역대 연말 0.80~1.48배) — 평소 대비 +42 가운데 P/E 쪽 -77 · ROE 쪽 +119. ROE 24.9% 는 평소의 3.3배다.
Of the 199 KOSPI 200 stocks, 199 have announced Q3 2026 results (199 quarterly reports). Operating profit of the companies that announced totals KRW 240.2trn — +291.1% YoY, +30.5% excluding the two largest and +19.4% also excluding holding companies. Operating profit rose at 102 companies and fell at 43. P/B is the yardstick for valuation. P/B of the same 109 companies with data since 2013 is 1.69x (year-ends on record 0.80–1.48x) — of the +42 against its usual level, the P/E part is -77 and the ROE part +119. ROE of 24.9% is 3.3 times its usual level.
KOSPI200の199銘柄のうち199社が2026年第3四半期の実績を発表した(四半期報告書199社)。発表企業の営業利益合計は240.2兆ウォン — 前年同期比+291.1%、最大2社を除くと+30.5%、持株会社も除くと+19.4%。営業利益が増えた企業102社 · 減った企業43社。バリュエーションの基準はPBRである。2013年からデータがある同じ109社のPBRは1.69倍(過去の年末0.80~1.48倍) — 平常値比+42のうちPER要因-77 · ROE要因+119。ROE 24.9%は平常値の3.3倍である。
01

누가 발표했나Who has announced発表済みの企業

현황Status状況KOSPI 200 companies that have announced Q3 2026 results, cumulative by date

Cumulative number of KOSPI 200 companies reporting Q3 2026 resultsnumber of companies · Data as of 2026-11-11 · Created 2026-11-17050.010015020010/110/2611/11companies152

K200 199종목 가운데 2026년 3분기 실적을 발표한 곳은 199곳, 그중 분기보고서까지 낸 곳은 199곳이다. 아직 발표하지 않은 곳은 0곳.

Of the 199 KOSPI 200 stocks, 199 have announced Q3 2026 results, and 199 of them have also filed the quarterly report. 0 have yet to announce.

KOSPI200の199銘柄のうち2026年第3四半期の実績を発表したのは199社で、そのうち四半期報告書まで提出したのは199社である。まだ発表していないのは0社。

⚠ 규율: 첫 발표 2026-10-01 · 공시 목록을 확인한 마지막 접수일 2026-11-11. 밸류에이션 화면의 숫자는 분기보고서가 나온 뒤에 바뀐다 — 이 페이지는 그 전의 발표값을 모은 것이다. 그 뒤에 들어온 분기보고서 197곳은 접수일을 따로 확인하지 않아 그림에는 발표 누적만 그렸다.

⚠ Discipline: First announcement 2026-10-01 · last filing date checked in the disclosure list 2026-11-11. The figures on the valuation pages change after the quarterly reports come out — this page collects the announced figures from before that. The 197 quarterly reports that arrived after that were not checked for their filing dates, so the chart shows only the cumulative announcements.

⚠ 規律:最初の発表:2026-10-01 · 開示一覧で確認した最後の受付日:2026-11-11。バリュエーション画面の数値は四半期報告書が出た後に変わる — このページはその前の発表値を集めたものである。その後に届いた四半期報告書197社は受付日を別途確認していないため、図には発表の累計だけを描いた。

Source: DART, Financial Supervisory Service.
Limitations: 잠정실적은 회사가 발표한 값으로 외부감사인 검토 전이다 · 발표한 회사만의 합계라 지수 전체가 아니며, 회사가 더 발표하면 달라진다 · 연결 기준 공시만 더했다(별도 기준으로 발표한 회사 · 달러로 공시하는 회사 · 월별 실적만 공시하는 회사는 뺐다) · 지주회사의 연결 실적에는 상장 자회사의 이익이 겹쳐 들어간다 · 전년동기·전분기 값은 각 공시에 적힌 값이다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Limitations: Preliminary results are the figures announced by the companies, before review by external auditors · the sums cover only the companies that have announced, not the whole index, and change as more companies announce · only consolidated-basis announcements are added (companies announcing on a separate basis, companies reporting in dollars and companies announcing monthly results only are left out) · holding companies' consolidated results double-count the profits of listed subsidiaries · year-earlier and previous-quarter figures are the values stated in each announcement.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Limitations: 速報値(暫定決算)は企業が発表した値で、外部監査人のレビュー前である · 発表した企業だけの合計で指数全体ではなく、発表が増えれば変わる · 連結ベースの開示のみを合算した(個別ベースで発表した企業 · ドルで開示する企業 · 月次実績のみ開示する企業は除いた) · 持株会社の連結実績には上場子会社の利益が重複して入る · 前年同期・前四半期の値は各開示に記載された値である。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

02

발표한 회사 합계 — 영업이익과 순이익Totals for the companies that announced — operating profit and net profit発表企業の合計 — 営業利益と純利益

합계Totals合計Operating profit of KOSPI 200 companies that announced Q3 2026 results

Operating profit, sum of companies that announced (consolidated basis)KRW trillions · Data as of 2026-11-11 · Created 2026-11-170100200300All announcersExcl. two largestAlso excl. holding cosKRW tnQ3 2025 (a year earlier)Q2 2026 (previous quarter)Q3 202661.437.932.920757.045.424049.439.3

발표한 회사 가운데 합계에 넣은 145사의 2026년 3분기 영업이익 합계 240.2조 — 전년 같은 분기 61.4조 대비 +291.1%, 전분기 대비 +16.1%. 영업이익이 가장 큰 두 곳을 빼면 49.4조 (전년비 +30.5% · 전분기비 -13.2%), 지주회사까지 빼면 39.3조 (전년비 +19.4%).

Of the companies that announced, the 145 included in the sums had total operating profit of KRW 240.2trn in Q3 2026 — +291.1% against KRW 61.4trn a year earlier and +16.1% against the previous quarter. Excluding the two companies with the largest operating profit: KRW 49.4trn (+30.5% YoY · -13.2% QoQ); also excluding holding companies: KRW 39.3trn (+19.4% YoY).

発表企業のうち合計に含めた145社の2026年第3四半期の営業利益合計は240.2兆ウォン — 前年同期の61.4兆ウォンに対して+291.1%、前期比+16.1%。営業利益が最も大きい2社を除くと49.4兆ウォン(前年同期比+30.5% · 前期比-13.2%)、持株会社も除くと39.3兆ウォン(前年同期比+19.4%)。

⚠ 규율: 영업이익이 늘어난 회사 102곳 · 줄어든 회사 43곳 · 영업적자 9곳(적자 전환 3 · 흑자 전환 6). 합계에 넣은 회사 가운데 지주회사 9곳은 이 사이트의 정기보고서 자료가 별도 재무제표라 공시의 지난 분기 값과 대조하지 못했다(공시 값 그대로 · 지주회사를 뺀 합계에는 없다).

⚠ Discipline: Operating profit up at 102 companies · down at 43 · operating loss at 9 (3 turned to a loss · 6 turned to a profit). For 9 holding companies in the sums, this site's periodic-report data are separate financial statements, so their announcements could not be checked against past-quarter values (announced values as they are · not in the sums that exclude holding companies).

⚠ 規律:営業利益が増えた企業102社 · 減った企業43社 · 営業赤字9社(赤字転落3 · 黒字転換6)。合計に含めた企業のうち持株会社9社は、このサイトの定期報告書データが個別財務諸表のため、開示の前四半期の値と照合できなかった(開示値のまま · 持株会社を除いた合計には含まれない)。

Source: DART, Financial Supervisory Service.
Limitations: 잠정실적은 회사가 발표한 값으로 외부감사인 검토 전이다 · 발표한 회사만의 합계라 지수 전체가 아니며, 회사가 더 발표하면 달라진다 · 연결 기준 공시만 더했다(별도 기준으로 발표한 회사 · 달러로 공시하는 회사 · 월별 실적만 공시하는 회사는 뺐다) · 지주회사의 연결 실적에는 상장 자회사의 이익이 겹쳐 들어간다 · 전년동기·전분기 값은 각 공시에 적힌 값이다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Limitations: Preliminary results are the figures announced by the companies, before review by external auditors · the sums cover only the companies that have announced, not the whole index, and change as more companies announce · only consolidated-basis announcements are added (companies announcing on a separate basis, companies reporting in dollars and companies announcing monthly results only are left out) · holding companies' consolidated results double-count the profits of listed subsidiaries · year-earlier and previous-quarter figures are the values stated in each announcement.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Limitations: 速報値(暫定決算)は企業が発表した値で、外部監査人のレビュー前である · 発表した企業だけの合計で指数全体ではなく、発表が増えれば変わる · 連結ベースの開示のみを合算した(個別ベースで発表した企業 · ドルで開示する企業 · 月次実績のみ開示する企業は除いた) · 持株会社の連結実績には上場子会社の利益が重複して入る · 前年同期・前四半期の値は各開示に記載された値である。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

합계Totals合計Net income of KOSPI 200 companies that announced Q3 2026 results

Net income, sum of companies that announced (consolidated basis)KRW trillions · Data as of 2026-11-11 · Created 2026-11-17050.0100150200250All announcersExcl. two largestAlso excl. holding cosKRW tnQ3 2025 (a year earlier)Q2 2026 (previous quarter)Q3 202654.029.226.520741.535.414429.021.8

순이익 합계 143.9조 — 전년비 +166.5% · 전분기비 -30.5%. 가장 큰 두 곳을 빼면 29.0조 (전년비 -0.7%), 지주회사까지 빼면 21.8조 (전년비 -17.5%).

Net profit in total KRW 143.9trn — +166.5% YoY · -30.5% QoQ. Excluding the two largest: KRW 29.0trn (-0.7% YoY); also excluding holding companies: KRW 21.8trn (-17.5% YoY).

純利益合計143.9兆ウォン — 前年同期比+166.5% · 前期比-30.5%。最も大きい2社を除くと29.0兆ウォン(前年同期比-0.7%)、持株会社も除くと21.8兆ウォン(前年同期比-17.5%)。

⚠ 규율: 순이익을 적지 않은 공시는 순이익 합계에서 빠진다(영업이익 145사 · 순이익 143사). 매출 합계 924조 (전년비 +48.9%).

⚠ Discipline: Announcements that do not state net profit drop out of the net-profit sum (operating profit: 145 companies · net profit: 143). Revenue in total KRW 924trn (+48.9% YoY).

⚠ 規律:純利益を記載していない開示は純利益の合計から外れる(営業利益145社 · 純利益143社)。売上高合計924兆ウォン(前年同期比+48.9%)。

Source: DART, Financial Supervisory Service.
Limitations: 잠정실적은 회사가 발표한 값으로 외부감사인 검토 전이다 · 발표한 회사만의 합계라 지수 전체가 아니며, 회사가 더 발표하면 달라진다 · 연결 기준 공시만 더했다(별도 기준으로 발표한 회사 · 달러로 공시하는 회사 · 월별 실적만 공시하는 회사는 뺐다) · 지주회사의 연결 실적에는 상장 자회사의 이익이 겹쳐 들어간다 · 전년동기·전분기 값은 각 공시에 적힌 값이다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Limitations: Preliminary results are the figures announced by the companies, before review by external auditors · the sums cover only the companies that have announced, not the whole index, and change as more companies announce · only consolidated-basis announcements are added (companies announcing on a separate basis, companies reporting in dollars and companies announcing monthly results only are left out) · holding companies' consolidated results double-count the profits of listed subsidiaries · year-earlier and previous-quarter figures are the values stated in each announcement.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Limitations: 速報値(暫定決算)は企業が発表した値で、外部監査人のレビュー前である · 発表した企業だけの合計で指数全体ではなく、発表が増えれば変わる · 連結ベースの開示のみを合算した(個別ベースで発表した企業 · ドルで開示する企業 · 月次実績のみ開示する企業は除いた) · 持株会社の連結実績には上場子会社の利益が重複して入る · 前年同期・前四半期の値は各開示に記載された値である。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

03

업종별 — 어디가 늘고 어디가 줄었나By sector — where profit rose and where it fell業種別 — どこが増え、どこが減ったか

업종Sectors業種Change in operating profit from a year earlier, by sector (largest sector shown separately)

Change in Q3 2026 operating profit versus Q3 2025, by sectorKRW trillions · Data as of 2026-11-11 · Created 2026-11-17-2.002.04.06.0FinanceConsumerHoldingIndustrialMaterialsEnergyHealthTelecomBatteryConstr.DefenseContentKRW tn-0.251.15.11.40.181.20.270.611.10.56-0.290.23
업종회사 수영업이익전년 같은 분기전년비전분기비늘어난 곳줄어든 곳영업적자
IT·반도체14192.83조25.45조+657.6%+26.9%860
금융1611.22조11.47조-2.1%-20.1%970
소비재3410.46조9.36조+11.8%-12.4%2680
지주1010.06조4.92조+104.3%-13.5%820
산업재185.52조4.07조+35.6%-8.7%1621
소재·화학·철강182.13조1.95조+9.3%-40.3%1172
에너지·유틸리티62.08조0.84조+147.3%+16.5%331
헬스케어101.40조1.13조+24.0%+7.9%721
통신31.36조0.75조+81.1%-13.1%210
2차전지71.10조-0.03조n/a+299.8%524
건설41.01조0.45조+123.4%+9.3%310
방산50.81조1.09조-26.2%-54.3%320
콘텐츠·엔터10.19조-0.04조n/a+10.3%100

전년비 n/a = 전년 같은 분기 합계가 적자라 비율을 내지 않았다.

SectorCompaniesOperating profitSame quarter a year earlierYoYQoQUpDownOperating loss
IT and semiconductors14KRW 192.83trnKRW 25.45trn+657.6%+26.9%860
Financials16KRW 11.22trnKRW 11.47trn-2.1%-20.1%970
Consumer34KRW 10.46trnKRW 9.36trn+11.8%-12.4%2680
Holding companies10KRW 10.06trnKRW 4.92trn+104.3%-13.5%820
Industrials18KRW 5.52trnKRW 4.07trn+35.6%-8.7%1621
Materials, chemicals and steel18KRW 2.13trnKRW 1.95trn+9.3%-40.3%1172
Energy and utilities6KRW 2.08trnKRW 0.84trn+147.3%+16.5%331
Healthcare10KRW 1.40trnKRW 1.13trn+24.0%+7.9%721
Telecoms3KRW 1.36trnKRW 0.75trn+81.1%-13.1%210
Secondary batteries7KRW 1.10trnKRW -0.03trnn/a+299.8%524
Construction4KRW 1.01trnKRW 0.45trn+123.4%+9.3%310
Defence5KRW 0.81trnKRW 1.09trn-26.2%-54.3%320
Content and entertainment1KRW 0.19trnKRW -0.04trnn/a+10.3%100

YoY n/a = the sum for the same quarter a year earlier was a loss, so no ratio is given.

業種企業数営業利益前年同期前年同期比前期比増加減少営業赤字
IT・半導体14192.83兆ウォン25.45兆ウォン+657.6%+26.9%860
金融1611.22兆ウォン11.47兆ウォン-2.1%-20.1%970
消費財3410.46兆ウォン9.36兆ウォン+11.8%-12.4%2680
持株会社1010.06兆ウォン4.92兆ウォン+104.3%-13.5%820
資本財185.52兆ウォン4.07兆ウォン+35.6%-8.7%1621
素材・化学・鉄鋼182.13兆ウォン1.95兆ウォン+9.3%-40.3%1172
エネルギー・公益62.08兆ウォン0.84兆ウォン+147.3%+16.5%331
ヘルスケア101.40兆ウォン1.13兆ウォン+24.0%+7.9%721
通信31.36兆ウォン0.75兆ウォン+81.1%-13.1%210
二次電池71.10兆ウォン-0.03兆ウォンn/a+299.8%524
建設41.01兆ウォン0.45兆ウォン+123.4%+9.3%310
防衛50.81兆ウォン1.09兆ウォン-26.2%-54.3%320
コンテンツ・エンタメ10.19兆ウォン-0.04兆ウォンn/a+10.3%100

前年同期比n/a = 前年同期の合計が赤字のため比率を出していない。

IT·반도체 업종은 따로 적는다: 영업이익 25.5조 → 192.8조(+167.4조). 나머지 업종의 전년 대비 증감: 지주 +5.13조 · 산업재 +1.45조 · 에너지·유틸리티 +1.24조 · 2차전지 +1.13조 · 소비재 +1.11조 · 통신 +0.61조 · 건설 +0.56조 · 헬스케어 +0.27조 · 콘텐츠·엔터 +0.23조 · 소재·화학·철강 +0.18조 · 금융 -0.25조 · 방산 -0.29조.

The IT and semiconductors sector is shown separately: operating profit KRW 25.5trn → KRW 192.8trn (KRW +167.4trn). Change from a year earlier in the other sectors: Holding companies KRW +5.13trn · Industrials KRW +1.45trn · Energy and utilities KRW +1.24trn · Secondary batteries KRW +1.13trn · Consumer KRW +1.11trn · Telecoms KRW +0.61trn · Construction KRW +0.56trn · Healthcare KRW +0.27trn · Content and entertainment KRW +0.23trn · Materials, chemicals and steel KRW +0.18trn · Financials KRW -0.25trn · Defence KRW -0.29trn.

IT・半導体業種は別に記す:営業利益25.5兆ウォン → 192.8兆ウォン(+167.4兆ウォン)。その他の業種の前年同期比増減:持株会社+5.13兆ウォン · 資本財+1.45兆ウォン · エネルギー・公益+1.24兆ウォン · 二次電池+1.13兆ウォン · 消費財+1.11兆ウォン · 通信+0.61兆ウォン · 建設+0.56兆ウォン · ヘルスケア+0.27兆ウォン · コンテンツ・エンタメ+0.23兆ウォン · 素材・化学・鉄鋼+0.18兆ウォン · 金融-0.25兆ウォン · 防衛-0.29兆ウォン。

⚠ 규율: 업종 구분은 이 사이트의 밸류에이션 분류다. 지주는 자회사 연결 실적이 겹친다.

⚠ Discipline: The sector split is this site's valuation classification. Holding companies overlap with their subsidiaries' consolidated results.

⚠ 規律:業種区分はこのサイトのバリュエーション分類である。持株会社は子会社の連結実績と重複する。

Source: DART, Financial Supervisory Service.
Limitations: 잠정실적은 회사가 발표한 값으로 외부감사인 검토 전이다 · 발표한 회사만의 합계라 지수 전체가 아니며, 회사가 더 발표하면 달라진다 · 연결 기준 공시만 더했다(별도 기준으로 발표한 회사 · 달러로 공시하는 회사 · 월별 실적만 공시하는 회사는 뺐다) · 지주회사의 연결 실적에는 상장 자회사의 이익이 겹쳐 들어간다 · 전년동기·전분기 값은 각 공시에 적힌 값이다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Limitations: Preliminary results are the figures announced by the companies, before review by external auditors · the sums cover only the companies that have announced, not the whole index, and change as more companies announce · only consolidated-basis announcements are added (companies announcing on a separate basis, companies reporting in dollars and companies announcing monthly results only are left out) · holding companies' consolidated results double-count the profits of listed subsidiaries · year-earlier and previous-quarter figures are the values stated in each announcement.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Limitations: 速報値(暫定決算)は企業が発表した値で、外部監査人のレビュー前である · 発表した企業だけの合計で指数全体ではなく、発表が増えれば変わる · 連結ベースの開示のみを合算した(個別ベースで発表した企業 · ドルで開示する企業 · 月次実績のみ開示する企業は除いた) · 持株会社の連結実績には上場子会社の利益が重複して入る · 前年同期・前四半期の値は各開示に記載された値である。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

업종Sectors業種Companies with higher and lower operating profit than a year earlier, by sector

Number of companies by direction of operating profit versus Q3 2025number of companies · Data as of 2026-11-11 · Created 2026-11-17010.020.030.040.0TechFinanceConsumerHoldingIndustrialMaterialsEnergyHealthTelecomBatteryConstr.DefensecompaniesHigher than a year earlierLower than a year earlier8.06.014.09.07.016.026.08.034.08.010.016.018.011.07.018.03.03.06.07.09.03.05.07.03.04.03.05.0

영업이익이 전년보다 늘어난 회사 비율이 높은 업종: 산업재 16/18 · 지주 8/10 · 헬스케어 7/9. 낮은 업종: 에너지·유틸리티 3/6 · 금융 9/16 · IT·반도체 8/14.

Sectors with the highest share of companies whose operating profit rose from a year earlier: Industrials 16/18 · Holding companies 8/10 · Healthcare 7/9. Lowest: Energy and utilities 3/6 · Financials 9/16 · IT and semiconductors 8/14.

営業利益が前年より増えた企業の比率が高い業種:資本財16/18 · 持株会社8/10 · ヘルスケア7/9。低い業種:エネルギー・公益3/6 · 金融9/16 · IT・半導体8/14。

⚠ 규율: 회사 수가 5곳 미만인 업종은 문장에서 뺐다(표에는 있다). 그림에는 회사 수가 많은 12개 업종만 그렸다 — 뺀 업종(콘텐츠·엔터)도 위 표에는 있다.

⚠ Discipline: Sectors with fewer than 5 companies are left out of the sentence (they are in the table). The chart shows only the 12 sectors with the most companies — the sectors left out (Content and entertainment) are also in the table above.

⚠ 規律:企業数が5社未満の業種は文から除いた(表にはある)。図には企業数が多い12業種だけを描いた — 除いた業種(コンテンツ・エンタメ)も上の表にはある。

Source: DART, Financial Supervisory Service.
Limitations: 그림은 회사 수가 많은 12개 업종만 — 콘텐츠·엔터 제외 · 잠정실적은 회사가 발표한 값으로 외부감사인 검토 전이다 · 발표한 회사만의 합계라 지수 전체가 아니며, 회사가 더 발표하면 달라진다 · 연결 기준 공시만 더했다(별도 기준으로 발표한 회사 · 달러로 공시하는 회사 · 월별 실적만 공시하는 회사는 뺐다) · 지주회사의 연결 실적에는 상장 자회사의 이익이 겹쳐 들어간다 · 전년동기·전분기 값은 각 공시에 적힌 값이다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Limitations: The chart shows only the 12 sectors with the most companies — Content and entertainment excluded · Preliminary results are the figures announced by the companies, before review by external auditors · the sums cover only the companies that have announced, not the whole index, and change as more companies announce · only consolidated-basis announcements are added (companies announcing on a separate basis, companies reporting in dollars and companies announcing monthly results only are left out) · holding companies' consolidated results double-count the profits of listed subsidiaries · year-earlier and previous-quarter figures are the values stated in each announcement.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Limitations: 図は企業数が多い12業種のみ — コンテンツ・エンタメを除外 · 速報値(暫定決算)は企業が発表した値で、外部監査人のレビュー前である · 発表した企業だけの合計で指数全体ではなく、発表が増えれば変わる · 連結ベースの開示のみを合算した(個別ベースで発表した企業 · ドルで開示する企業 · 月次実績のみ開示する企業は除いた) · 持株会社の連結実績には上場子会社の利益が重複して入る · 前年同期・前四半期の値は各開示に記載された値である。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

04

밸류에이션 — 기준은 P/B, 그리고 P/B 와 P/E 의 차이Valuation — P/B as the yardstick, and the gap between P/B and P/Eバリュエーション — 基準はPBR、そしてPBRとPERの差

P/B 밴드P/B bandPBRバンドKOSPI 200 constituents: market value against book-value bands, year-ends since 2013

Market value and book value times historical P/B levels, same companies throughoutKRW trillions · Data as of 2026-11-12 · Created 2026-11-1701,0002,0003,0004,0005,000'13'15'17'19'21'23'25NowKRW tnMarket valueBook value × highest year-end P/BBook value × upper quartileBook value × medianBook value × lower quartileBook value × lowest year-end P/B

같은 109사의 P/B 는 2013년 말부터 2025년 말까지 연말 기준 0.80~1.48배(가운데 1.11배) 사이에 있었다. 지금(2026-11-12) 1.69배 — 13번의 연말 어느 때보다 높다. 2026년 9월 말 에는 2.23배였다.

Between end-2013 and end-2025, the P/B of the same 109 companies ranged 0.80–1.48x at year-ends (median 1.11x). Now (2026-11-12) 1.69x — higher than at any of the 13 year-ends. At end-September 2026 it was 2.23x.

同じ109社のPBRは2013年末から2025年末まで年末ベースで0.80~1.48倍(中央値1.11倍)の間にあった。現在(2026-11-12)1.69倍 — 13回の年末のどの時点よりも高い。2026年9月末には2.23倍だった。

⚠ 규율: 선은 그 시점의 자본에 역대 연말 P/B 의 최고·위 4분의 1·가운데·아래 4분의 1·최저를 곱한 값이다. 오른쪽 끝 두 점은 2026년 9월 말과 지금. 금융을 포함한 197사 전체의 지금 P/B 는 1.47배 · 금융 22사는 2021년부터만 자료가 있어 따로 — 연말 P/B 0.55 · 0.39 · 0.43 · 0.52 · 0.69 → 지금 0.62배.

⚠ Discipline: The lines are equity at each point multiplied by the highest, upper-quartile, median, lower-quartile and lowest year-end P/B on record. The two points at the right end are end-September 2026 and now. Including financials, P/B for all 197 companies is now 1.47x · the 22 financial companies have data only from 2021 onwards, so they are shown separately — year-end P/B 0.55 · 0.39 · 0.43 · 0.52 · 0.69 → now 0.62x.

⚠ 規律:線はその時点の自己資本に過去の年末PBRの最高・上位4分の1・中央値・下位4分の1・最低を掛けた値である。右端の二点は2026年9月末と現在。金融を含む197社全体の現在のPBRは1.47倍 · 金融22社は2021年以降のデータしかないため別に示す — 年末PBR 0.55 · 0.39 · 0.43 · 0.52 · 0.69 → 現在0.62倍。

Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: 2013년부터 매 연말 자료가 있는 같은 109사만 더했다(지금 K200 시가총액의 75%) — 금융회사와 상장이 늦은 회사는 긴 기간의 재무 자료가 없어 빠진다 · 지금의 구성종목을 과거로 거슬러 본 것이라 당시의 지수와 다르다 · 자본과 순이익은 비지배지분을 포함한 값이라 종목 화면의 P/B 와 조금 다르다 · 지주회사는 별도 재무제표 · 시가총액은 보통주와 우선주 합(회사가 들고 있는 자사주를 빼지 않았다) · 연말 값이라 연중 고점과 저점은 잡히지 않는다 · 2013년 이전은 자료가 없다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: Only the same 109 companies with data at every year-end since 2013 are added (now 75% of KOSPI 200 market capitalisation) — financial companies and later listings drop out because they lack long financial histories · today's constituents are traced back in time, so this differs from the index as it was then · equity and net profit include non-controlling interests, so P/B differs slightly from the stock pages · holding companies use separate financial statements · market capitalisation is common plus preferred shares (treasury shares held by the company are not deducted) · year-end values, so intra-year highs and lows are not captured · there are no data before 2013.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: 2013年から毎年末のデータがある同じ109社だけを合算した(現在のKOSPI200時価総額の75%) — 金融会社と上場が遅い企業は長期の財務データがないため外れる · 現在の構成銘柄を過去にさかのぼって見たもので、当時の指数とは異なる · 自己資本と純利益は非支配持分を含む値のため、銘柄画面のPBRとは少し異なる · 持株会社は個別財務諸表 · 時価総額は普通株と優先株の合計(会社が保有する自己株式は差し引いていない) · 年末の値のため年中の高値と安値は捉えられない · 2013年より前のデータはない。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

P/BP/BPBRP/B of the same companies at year-ends, at the latest quarter-end and now

Price-to-book of the same KOSPI 200 companiestimes book · Data as of 2026-11-12 · Created 2026-11-1700.51.01.52.02.5'16'17'18'19'20'21'22'23'24'25Sep '26Nowx1.11.30.931.11.41.20.861.00.81.52.21.7

연말 P/B: 2013 1.25 · 2014 1.11 · 2015 1.09 · 2016 1.11 · 2017 1.26 · 2018 0.93 · 2019 1.05 · 2020 1.38 · 2021 1.24 · 2022 0.86 · 2023 1.05 · 2024 0.80 · 2025 1.48. 2026년 9월 말 2.23 → 지금 1.69.

Year-end P/B: 2013 1.25 · 2014 1.11 · 2015 1.09 · 2016 1.11 · 2017 1.26 · 2018 0.93 · 2019 1.05 · 2020 1.38 · 2021 1.24 · 2022 0.86 · 2023 1.05 · 2024 0.80 · 2025 1.48; end-September 2026 2.23 → now 1.69.

年末PBR:2013 1.25 · 2014 1.11 · 2015 1.09 · 2016 1.11 · 2017 1.26 · 2018 0.93 · 2019 1.05 · 2020 1.38 · 2021 1.24 · 2022 0.86 · 2023 1.05 · 2024 0.80 · 2025 1.48。2026年9月末 2.23 → 現在1.69。

⚠ 규율: 같은 기간 P/E 는 9.4~27.9배, ROE 는 3.8~11.4% 사이를 오갔다 — 셋 가운데 P/B 가 가장 덜 움직였다(최고 ÷ 최저: P/B 1.8배 · P/E 3.0배 · ROE 3.0배).

⚠ Discipline: Over the same period P/E ranged 9.4–27.9x and ROE 3.8–11.4% — of the three, P/B moved the least (highest ÷ lowest: P/B 1.8x · P/E 3.0x · ROE 3.0x).

⚠ 規律:同じ期間にPERは9.4~27.9倍、ROEは3.8~11.4%の間を動いた — 三つのうちPBRが最も動かなかった(最高 ÷ 最低:PBR 1.8倍 · PER 3.0倍 · ROE 3.0倍)。

Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: 2013년부터 매 연말 자료가 있는 같은 109사만 더했다(지금 K200 시가총액의 75%) — 금융회사와 상장이 늦은 회사는 긴 기간의 재무 자료가 없어 빠진다 · 지금의 구성종목을 과거로 거슬러 본 것이라 당시의 지수와 다르다 · 자본과 순이익은 비지배지분을 포함한 값이라 종목 화면의 P/B 와 조금 다르다 · 지주회사는 별도 재무제표 · 시가총액은 보통주와 우선주 합(회사가 들고 있는 자사주를 빼지 않았다) · 연말 값이라 연중 고점과 저점은 잡히지 않는다 · 2013년 이전은 자료가 없다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: Only the same 109 companies with data at every year-end since 2013 are added (now 75% of KOSPI 200 market capitalisation) — financial companies and later listings drop out because they lack long financial histories · today's constituents are traced back in time, so this differs from the index as it was then · equity and net profit include non-controlling interests, so P/B differs slightly from the stock pages · holding companies use separate financial statements · market capitalisation is common plus preferred shares (treasury shares held by the company are not deducted) · year-end values, so intra-year highs and lows are not captured · there are no data before 2013.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: 2013年から毎年末のデータがある同じ109社だけを合算した(現在のKOSPI200時価総額の75%) — 金融会社と上場が遅い企業は長期の財務データがないため外れる · 現在の構成銘柄を過去にさかのぼって見たもので、当時の指数とは異なる · 自己資本と純利益は非支配持分を含む値のため、銘柄画面のPBRとは少し異なる · 持株会社は個別財務諸表 · 時価総額は普通株と優先株の合計(会社が保有する自己株式は差し引いていない) · 年末の値のため年中の高値と安値は捉えられない · 2013年より前のデータはない。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

P/B − P/EP/B − P/EPBR − PERP/B against its own average, split into a P/E part and an ROE part

P/B gap to its own average = P/E part + ROE part, same companieslog points (100 × log ratio) · Data as of 2026-11-12 · Created 2026-11-17-100-50.0050.0100150'16'17'18'19'20'21'22'23'24'25Sep '26Nowlog ptsP/B vs 2013-2025 averageof which P/E (multiple)of which ROE (earnings cycle)11942.2-77.0

P/B = P/E × ROE 이므로 P/B 와 P/E 의 차이는 ROE 다. 평소(2013~2025년 연말 평균)는 P/B 1.11배 · P/E 14.7배 · ROE 7.6%. 지금 P/B 가 평소보다 높은 정도 +42 = P/E 쪽 -77 + ROE 쪽 +119: ROE 24.9% 는 평소의 3.3배이고 P/E 6.8배는 평소보다 낮다. 2026년 9월 말: P/B +70 = P/E -49 + ROE +119(P/E 8.9배 · ROE 24.9%). 이번 분기 잠정실적을 얹으면 ROE 24.9% · P/E 6.8배 — P/B 는 그대로다.

Since P/B = P/E × ROE, the gap between P/B and P/E is ROE. The usual level (average of the 2013–2025 year-ends) is P/B 1.11x · P/E 14.7x · ROE 7.6%. P/B against its usual level now: +42 = P/E part -77 + ROE part +119: ROE of 24.9% is 3.3 times its usual level, and P/E of 6.8x is below its usual level. end-September 2026: P/B +70 = P/E -49 + ROE +119 (P/E 8.9x · ROE 24.9%). Adding this quarter's preliminary results gives ROE 24.9% · P/E 6.8x — P/B stays the same.

PBR = PER × ROEなので、PBRとPERの差はROEである。平常値(2013~2025年の年末平均)はPBR 1.11倍 · PER 14.7倍 · ROE 7.6%。現在のPBRの平常値比+42 = PER要因-77 + ROE要因+119:ROE 24.9%は平常値の3.3倍で、PER 6.8倍は平常値より低い。2026年9月末:PBR +70 = PER -49 + ROE +119(PER 8.9倍 · ROE 24.9%)。今四半期の速報値を加えるとROE 24.9% · PER 6.8倍 — PBRは変わらない。

⚠ 규율: 단위는 로그 차이 × 100(+69 가 2배). ROE = 직전 4개 분기 순이익 ÷ 자본. 잠정실적은 0곳(이 표본 시가총액의 0%)에 얹었고, 자본은 직전 분기 값 그대로다.

⚠ Discipline: Units are log difference × 100 (+69 = double). ROE = trailing four-quarter net profit ÷ equity. Preliminary results were added for 0 companies (0% of this sample's market capitalisation); equity is left at the previous quarter's value.

⚠ 規律:単位は対数差×100(+69が2倍)。ROE = 直近4四半期の純利益 ÷ 自己資本。速報値は0社(この標本の時価総額の0%)に加え、自己資本は前四半期の値のままである。

Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: 2013년부터 매 연말 자료가 있는 같은 109사만 더했다(지금 K200 시가총액의 75%) — 금융회사와 상장이 늦은 회사는 긴 기간의 재무 자료가 없어 빠진다 · 지금의 구성종목을 과거로 거슬러 본 것이라 당시의 지수와 다르다 · 자본과 순이익은 비지배지분을 포함한 값이라 종목 화면의 P/B 와 조금 다르다 · 지주회사는 별도 재무제표 · 시가총액은 보통주와 우선주 합(회사가 들고 있는 자사주를 빼지 않았다) · 연말 값이라 연중 고점과 저점은 잡히지 않는다 · 2013년 이전은 자료가 없다. · 잠정실적은 회사 발표값(외부감사인 검토 전).
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: Only the same 109 companies with data at every year-end since 2013 are added (now 75% of KOSPI 200 market capitalisation) — financial companies and later listings drop out because they lack long financial histories · today's constituents are traced back in time, so this differs from the index as it was then · equity and net profit include non-controlling interests, so P/B differs slightly from the stock pages · holding companies use separate financial statements · market capitalisation is common plus preferred shares (treasury shares held by the company are not deducted) · year-end values, so intra-year highs and lows are not captured · there are no data before 2013. · preliminary results are company-announced figures (before review by external auditors).
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: 2013年から毎年末のデータがある同じ109社だけを合算した(現在のKOSPI200時価総額の75%) — 金融会社と上場が遅い企業は長期の財務データがないため外れる · 現在の構成銘柄を過去にさかのぼって見たもので、当時の指数とは異なる · 自己資本と純利益は非支配持分を含む値のため、銘柄画面のPBRとは少し異なる · 持株会社は個別財務諸表 · 時価総額は普通株と優先株の合計(会社が保有する自己株式は差し引いていない) · 年末の値のため年中の高値と安値は捉えられない · 2013年より前のデータはない。 · 速報値は企業の発表値(外部監査人のレビュー前)。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

종목Stocks銘柄Where each company's P/B sits within its own history, by sector

Number of companies by position of today's P/B within their own year-end rangenumber of companies · Data as of 2026-11-12 · Created 2026-11-17010.020.030.040.050.0ConsumerMaterialsIndustrialHoldingTechHealthEnergyDefenseConstr.TelecomcompaniesAbove own highest year-endUpper quarter of own rangeMiddle halfLower quarterBelow own lowest year-end12.018.09.041.06.011.08.027.08.07.017.06.04.017.014.05.010.08.04.04.03.0

역대 최고보다 높은 8곳 — 삼성전자, 삼성전기, LS ELECTRIC, 한미반도체, 한진칼, GS, 대우건설, 한올바이오파마

역대 최저보다 낮은 29곳 — 삼성E&A, NAVER, 카카오, 엔씨소프트, LG생활건강, 강원랜드, 넷마블, CJ제일제당, 금호석유, 롯데지주, 롯데케미칼, 제일기획, 이마트, 한전KPS, 만도, CJ대한통운, 오뚜기, 대웅제약, 하이트진로, 롯데칠성, 대웅, 종근당, 롯데정밀화학, SK케미칼, 미원에스씨, 동원시스템즈, TKG휴켐스, 대한유화, 영풍

8 above their highest year-end — Samsung Electronics, Samsung Electro-Mechanics, LS ELECTRIC, Hanmi Semiconductor, Hanjinkal, GS, Daewoo Engineering & Construction, Hanall Biopharma

29 below their lowest year-end — Samsung C&T, NAVER, Kakao, NC, LG H&H, Kangwon Land, Netmarble, CJ Cheiljedang, Kumho Petro Chemical, Lotte, Lotte Chemical, Cheil Worldwide, E-Mart, KEPCO Plant Service & Engineering, HL Mando, CJ Logistics, Otoki, Daewoong Pharma, Hite Jinro, Lotte Chilsung Beverage, Daewoong, Chong Kun Dang Pharmaceutical, LOTTE Fine Chemical, SK Chemicals, Miwon Specialty Chemical, Dongwon Systems, TKG Huchems, Korea Petro Chemical IND, Youngpoong

過去最高を上回る8社 — Samsung Electronics、Samsung Electro-Mechanics、LS ELECTRIC、Hanmi Semiconductor、Hanjinkal、GS、Daewoo Engineering & Construction、Hanall Biopharma

過去最低を下回る29社 — Samsung C&T、NAVER、Kakao、NC、LG H&H、Kangwon Land、Netmarble、CJ Cheiljedang、Kumho Petro Chemical、Lotte、Lotte Chemical、Cheil Worldwide、E-Mart、KEPCO Plant Service & Engineering、HL Mando、CJ Logistics、Otoki、Daewoong Pharma、Hite Jinro、Lotte Chilsung Beverage、Daewoong、Chong Kun Dang Pharmaceutical、LOTTE Fine Chemical、SK Chemicals、Miwon Specialty Chemical、Dongwon Systems、TKG Huchems、Korea Petro Chemical IND、Youngpoong

지수의 P/B 는 밴드 위쪽이지만 종목은 갈린다. 자기 역대 연말 범위와 견주면: 역대 최고보다 높은 곳 8곳 · 위 4분의 1 28곳 · 가운데 46곳 · 아래 4분의 1 37곳 · 역대 최저보다 낮은 곳 29곳.

The index P/B is in the upper part of its band, but individual stocks diverge. Against their own year-end ranges: above their highest 8 · upper quarter 28 · middle 46 · lower quarter 37 · below their lowest 29.

指数のPBRはバンドの上方にあるが、銘柄は分かれる。自社の過去の年末レンジと比べると:過去最高を上回る8社 · 上位4分の1 28社 · 中央46社 · 下位4分の1 37社 · 過去最低を下回る29社。

⚠ 규율: 회사 수가 3곳 미만인 업종은 그림에서 뺐다.

⚠ Discipline: Sectors with fewer than 3 companies are left out of the chart.

⚠ 規律:企業数が3社未満の業種は図から除いた。

Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: 그림은 회사 수가 3곳 이상인 업종만 · 연말 자료가 8개 이상 있는 148사(금융회사와 상장이 늦은 회사 제외) · 범위는 그 회사의 연말 P/B(연중 고점·저점 아님) · 평소 P/E·ROE 는 이익이 난 해만의 평균 · 자본과 순이익은 비지배지분 포함 · 지주회사는 별도 재무제표 · 시가총액은 보통주와 우선주 합.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: The chart shows only sectors with 3 or more companies · The 148 companies with at least 8 year-ends of data (financial companies and later listings excluded) · the range is the company's own year-end P/B (not intra-year highs and lows) · usual P/E and ROE are averages over profitable years only · equity and net profit include non-controlling interests · holding companies use separate financial statements · market capitalisation is common plus preferred shares.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: 図は企業数が3社以上の業種のみ · 年末データが8つ以上ある148社(金融会社と上場が遅い企業を除く) · 範囲はその企業の年末PBR(年中の高値・安値ではない) · 平常のPER・ROEは利益が出た年のみの平均 · 自己資本と純利益は非支配持分を含む · 持株会社は個別財務諸表 · 時価総額は普通株と優先株の合計。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

종목Stocks銘柄P/B gap to own average by sector: how much is multiple, how much is earnings

Median company by sector: P/E part and ROE part of the P/B gap to own averagelog points (100 × log ratio) · Data as of 2026-11-12 · Created 2026-11-17-100-50.0050.0100ConsumerMaterialsIndustrialHoldingTechHealthEnergyDefenseConstr.Telecomlog ptsP/E part (multiple)ROE part (earnings cycle)

업종별 가운데 회사의 P/B 평소 대비 = P/E 쪽 + ROE 쪽: 소비재 -41 = -27 + -13 · 소재·화학·철강 -41 = -32 + -4 · 산업재 +14 = -32 + +69 · 지주 +18 = -50 + +64 · IT·반도체 -10 = -24 + +38 · 헬스케어 -53 = -78 + +43 · 에너지·유틸리티 +5 = -58 + +54 · 방산 +50 = -1 + +45 · 건설 +40 = +36 + -14 · 통신 +16 = -2 + +2.

Median company by sector, P/B against its usual level = P/E part + ROE part: Consumer -41 = -27 + -13 · Materials, chemicals and steel -41 = -32 + -4 · Industrials +14 = -32 + +69 · Holding companies +18 = -50 + +64 · IT and semiconductors -10 = -24 + +38 · Healthcare -53 = -78 + +43 · Energy and utilities +5 = -58 + +54 · Defence +50 = -1 + +45 · Construction +40 = +36 + -14 · Telecoms +16 = -2 + +2.

業種別の中央値の企業のPBR平常値比 = PER要因 + ROE要因:消費財 -41 = -27 + -13 · 素材・化学・鉄鋼 -41 = -32 + -4 · 資本財 +14 = -32 + +69 · 持株会社 +18 = -50 + +64 · IT・半導体 -10 = -24 + +38 · ヘルスケア -53 = -78 + +43 · エネルギー・公益 +5 = -58 + +54 · 防衛 +50 = -1 + +45 · 建設 +40 = +36 + -14 · 通信 +16 = -2 + +2。

⚠ 규율: 가운데 회사 값이라 두 몫의 합이 P/B 쪽 값과 꼭 맞지는 않는다. 이익이 난 해가 5개 미만인 회사는 빠진다.

⚠ Discipline: These are median-company values, so the two parts do not necessarily add up to the P/B value. Companies with fewer than 5 profitable years are left out.

⚠ 規律:中央値の企業の値のため、二つの要因の和がPBRの値と必ずしも一致しない。利益が出た年が5つ未満の企業は除く。

Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: 연말 자료가 8개 이상 있는 148사(금융회사와 상장이 늦은 회사 제외) · 범위는 그 회사의 연말 P/B(연중 고점·저점 아님) · 평소 P/E·ROE 는 이익이 난 해만의 평균 · 자본과 순이익은 비지배지분 포함 · 지주회사는 별도 재무제표 · 시가총액은 보통주와 우선주 합.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: The 148 companies with at least 8 year-ends of data (financial companies and later listings excluded) · the range is the company's own year-end P/B (not intra-year highs and lows) · usual P/E and ROE are averages over profitable years only · equity and net profit include non-controlling interests · holding companies use separate financial statements · market capitalisation is common plus preferred shares.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: 年末データが8つ以上ある148社(金融会社と上場が遅い企業を除く) · 範囲はその企業の年末PBR(年中の高値・安値ではない) · 平常のPER・ROEは利益が出た年のみの平均 · 自己資本と純利益は非支配持分を含む · 持株会社は個別財務諸表 · 時価総額は普通株と優先株の合計。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

표Table表The largest companies: today's P/B within its own range, and the split

회사P/B 지금역대 연말 최저~최고(가운데)위치P/E 지금(평소)ROE 지금(평소)P/B 평소 대비배수 쪽이익 쪽
삼성전자2.200.88~1.97 (1.43)역대 최고 위6.3 (11.8)34.8% (11.7%)+46-63+109
SK하이닉스2.960.86~3.93 (1.65)위 4분의 14.8 (9.7)61.2% (15.9%)+65-69+135
삼성전기6.390.89~2.29 (1.45)역대 최고 위51.9 (25.0)12.3% (5.7%)+149+73+76
삼성바이오로직스7.725.50~11.97 (6.54)가운데37.2 (95.7)20.7% (8.1%)-1-94+94
현대차0.490.40~1.07 (0.55)가운데7.3 (6.1)6.7% (9.5%)-17+18-35
셀트리온2.781.72~14.14 (6.02)가운데36.6 (65.6)7.6% (7.7%)-60-58-1
삼성E&A0.570.77~1.63 (0.92)역대 최저 아래27.5 (25.1)2.1% (3.9%)-55+9-64
삼성SDI1.540.68~3.27 (1.24)가운데39.7 (38.2)3.9% (3.6%)+12+4+8
기아0.590.50~1.12 (0.78)아래 4분의 15.3 (7.4)11.1% (10.0%)-24-34+10
SK2.120.65~10.03 (1.35)위 4분의 132.6 (18.4)6.5% (9.2%)+23+57-34
한화에어로스페이스1.760.48~2.89 (0.86)위 4분의 113.2 (16.5)13.4% (5.9%)+58-23+81
현대모비스0.640.48~1.41 (0.73)가운데9.6 (9.0)6.7% (8.2%)-15+6-21
두산에너빌리티2.630.19~4.02 (0.47)위 4분의 185.4 (53.5)3.1% (2.2%)+82+47+35
NAVER0.951.17~16.18 (4.73)역대 최저 아래17.7 (28.9)5.4% (13.4%)-141-49-92
LG전자0.790.55~1.32 (0.74)가운데13.1 (20.2)6.0% (3.9%)-1-43+42

시가총액 기준일 2026-11-12.

CompanyP/B nowYear-end low–high on record (median)PositionP/E now (usual)ROE now (usual)P/B vs usualMultiple partEarnings part
Samsung Electronics2.200.88~1.97 (1.43)Above own record high6.3 (11.8)34.8% (11.7%)+46-63+109
SK hynix2.960.86~3.93 (1.65)Upper quarter4.8 (9.7)61.2% (15.9%)+65-69+135
Samsung Electro-Mechanics6.390.89~2.29 (1.45)Above own record high51.9 (25.0)12.3% (5.7%)+149+73+76
Samsung Biologics7.725.50~11.97 (6.54)Middle37.2 (95.7)20.7% (8.1%)-1-94+94
Hyundai Motor0.490.40~1.07 (0.55)Middle7.3 (6.1)6.7% (9.5%)-17+18-35
Celltrion2.781.72~14.14 (6.02)Middle36.6 (65.6)7.6% (7.7%)-60-58-1
Samsung C&T0.570.77~1.63 (0.92)Below own record low27.5 (25.1)2.1% (3.9%)-55+9-64
Samsung SDI1.540.68~3.27 (1.24)Middle39.7 (38.2)3.9% (3.6%)+12+4+8
Kia0.590.50~1.12 (0.78)Lower quarter5.3 (7.4)11.1% (10.0%)-24-34+10
SK2.120.65~10.03 (1.35)Upper quarter32.6 (18.4)6.5% (9.2%)+23+57-34
Hanwha Aerospace1.760.48~2.89 (0.86)Upper quarter13.2 (16.5)13.4% (5.9%)+58-23+81
Hyundai Mobis0.640.48~1.41 (0.73)Middle9.6 (9.0)6.7% (8.2%)-15+6-21
Doosan Enerbility2.630.19~4.02 (0.47)Upper quarter85.4 (53.5)3.1% (2.2%)+82+47+35
NAVER0.951.17~16.18 (4.73)Below own record low17.7 (28.9)5.4% (13.4%)-141-49-92
LG Electronics0.790.55~1.32 (0.74)Middle13.1 (20.2)6.0% (3.9%)-1-43+42

Market capitalisation as of 2026-11-12.

企業現在のPBR過去の年末 最低~最高(中央値)位置現在のPER(平常値)現在のROE(平常値)PBRの平常値比倍率要因利益要因
Samsung Electronics2.200.88~1.97 (1.43)過去最高超6.3 (11.8)34.8% (11.7%)+46-63+109
SK hynix2.960.86~3.93 (1.65)上位4分の14.8 (9.7)61.2% (15.9%)+65-69+135
Samsung Electro-Mechanics6.390.89~2.29 (1.45)過去最高超51.9 (25.0)12.3% (5.7%)+149+73+76
Samsung Biologics7.725.50~11.97 (6.54)中央37.2 (95.7)20.7% (8.1%)-1-94+94
Hyundai Motor0.490.40~1.07 (0.55)中央7.3 (6.1)6.7% (9.5%)-17+18-35
Celltrion2.781.72~14.14 (6.02)中央36.6 (65.6)7.6% (7.7%)-60-58-1
Samsung C&T0.570.77~1.63 (0.92)過去最低未満27.5 (25.1)2.1% (3.9%)-55+9-64
Samsung SDI1.540.68~3.27 (1.24)中央39.7 (38.2)3.9% (3.6%)+12+4+8
Kia0.590.50~1.12 (0.78)下位4分の15.3 (7.4)11.1% (10.0%)-24-34+10
SK2.120.65~10.03 (1.35)上位4分の132.6 (18.4)6.5% (9.2%)+23+57-34
Hanwha Aerospace1.760.48~2.89 (0.86)上位4分の113.2 (16.5)13.4% (5.9%)+58-23+81
Hyundai Mobis0.640.48~1.41 (0.73)中央9.6 (9.0)6.7% (8.2%)-15+6-21
Doosan Enerbility2.630.19~4.02 (0.47)上位4分の185.4 (53.5)3.1% (2.2%)+82+47+35
NAVER0.951.17~16.18 (4.73)過去最低未満17.7 (28.9)5.4% (13.4%)-141-49-92
LG Electronics0.790.55~1.32 (0.74)中央13.1 (20.2)6.0% (3.9%)-1-43+42

時価総額の基準日:2026-11-12。

시가총액이 큰 15곳. P/B 평소 대비 = 배수(P/E) 쪽 + 이익(ROE) 쪽 — 로그 차이 × 100.

The 15 largest companies by market capitalisation. P/B against its usual level = multiple (P/E) part + earnings (ROE) part — log difference × 100.

時価総額が大きい15社。PBRの平常値比 = 倍率(PER)要因 + 利益(ROE)要因 — 対数差×100。

⚠ 규율: 적자이거나 이익이 난 해가 적어 나눌 수 없는 칸은 n/a.

⚠ Discipline: Cells that cannot be split because of a loss or too few profitable years are n/a.

⚠ 規律:赤字、または利益が出た年が少なく分けられない欄はn/a。

Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: 연말 자료가 8개 이상 있는 148사(금융회사와 상장이 늦은 회사 제외) · 범위는 그 회사의 연말 P/B(연중 고점·저점 아님) · 평소 P/E·ROE 는 이익이 난 해만의 평균 · 자본과 순이익은 비지배지분 포함 · 지주회사는 별도 재무제표 · 시가총액은 보통주와 우선주 합.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: The 148 companies with at least 8 year-ends of data (financial companies and later listings excluded) · the range is the company's own year-end P/B (not intra-year highs and lows) · usual P/E and ROE are averages over profitable years only · equity and net profit include non-controlling interests · holding companies use separate financial statements · market capitalisation is common plus preferred shares.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: 年末データが8つ以上ある148社(金融会社と上場が遅い企業を除く) · 範囲はその企業の年末PBR(年中の高値・安値ではない) · 平常のPER・ROEは利益が出た年のみの平均 · 自己資本と純利益は非支配持分を含む · 持株会社は個別財務諸表 · 時価総額は普通株と優先株の合計。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

05

회사별By company企業別

표Table表Largest operating profits among companies that announced

회사발표일매출영업이익전년 같은 분기전분기순이익
삼성전자10-29195.25조107.44조12.17조89.49조75.14조
SK하이닉스10-28104.62조83.33조11.38조60.54조39.78조
SK이노베이션10-2928.77조3.70조5,856억3.49조2.64조
HD현대10-2822.08조2.92조1.70조4.12조1.38조
현대차10-2945.11조2.68조2.54조2.85조1.93조
KB금융11-1124.50조2.37조2.33조2.71조1.76조
신한지주10-2718.64조1.91조1.95조2.48조1.61조
기아10-3031.60조1.82조1.46조2.63조1.29조
하나금융지주10-2320.00조1.63조1.48조1.59조1.26조
HD한국조선해양10-288.29조1.45조1.05조1.65조7,770억
우리금융지주10-2313.30조1.42조9,880억1.32조1.08조
S-Oil11-0211.97조1.41조2,292억9,650억1.44조
GS11-057.27조1.27조8,706억1.72조6,804억
삼성물산10-2812.01조1.14조9,934억1.03조8,009억
iM금융지주10-2610.47조1.03조9,767억9,151억7,712억

연결 기준 · 발표값.

CompanyAnnouncedRevenueOperating profitSame quarter a year earlierPrevious quarterNet profit
Samsung Electronics10-29KRW 195.25trnKRW 107.44trnKRW 12.17trnKRW 89.49trnKRW 75.14trn
SK hynix10-28KRW 104.62trnKRW 83.33trnKRW 11.38trnKRW 60.54trnKRW 39.78trn
SK Innovation10-29KRW 28.77trnKRW 3.70trn5,856 KRW 100mnKRW 3.49trnKRW 2.64trn
HD Hyundai10-28KRW 22.08trnKRW 2.92trnKRW 1.70trnKRW 4.12trnKRW 1.38trn
Hyundai Motor10-29KRW 45.11trnKRW 2.68trnKRW 2.54trnKRW 2.85trnKRW 1.93trn
KB Financial Group11-11KRW 24.50trnKRW 2.37trnKRW 2.33trnKRW 2.71trnKRW 1.76trn
Shinhan Financial Group10-27KRW 18.64trnKRW 1.91trnKRW 1.95trnKRW 2.48trnKRW 1.61trn
Kia10-30KRW 31.60trnKRW 1.82trnKRW 1.46trnKRW 2.63trnKRW 1.29trn
Hana Financial Group10-23KRW 20.00trnKRW 1.63trnKRW 1.48trnKRW 1.59trnKRW 1.26trn
HD Korea Shipbuilding & Offshore Engineering10-28KRW 8.29trnKRW 1.45trnKRW 1.05trnKRW 1.65trn7,770 KRW 100mn
Woori Financial Group10-23KRW 13.30trnKRW 1.42trn9,880 KRW 100mnKRW 1.32trnKRW 1.08trn
S-Oil11-02KRW 11.97trnKRW 1.41trn2,292 KRW 100mn9,650 KRW 100mnKRW 1.44trn
GS11-05KRW 7.27trnKRW 1.27trn8,706 KRW 100mnKRW 1.72trn6,804 KRW 100mn
Samsung C&T10-28KRW 12.01trnKRW 1.14trn9,934 KRW 100mnKRW 1.03trn8,009 KRW 100mn
Industrial Bank OF Korea10-26KRW 10.47trnKRW 1.03trn9,767 KRW 100mn9,151 KRW 100mn7,712 KRW 100mn

Consolidated basis · announced figures.

企業発表日売上高営業利益前年同期前四半期純利益
Samsung Electronics10-29195.25兆ウォン107.44兆ウォン12.17兆ウォン89.49兆ウォン75.14兆ウォン
SK hynix10-28104.62兆ウォン83.33兆ウォン11.38兆ウォン60.54兆ウォン39.78兆ウォン
SK Innovation10-2928.77兆ウォン3.70兆ウォン5,856億ウォン3.49兆ウォン2.64兆ウォン
HD Hyundai10-2822.08兆ウォン2.92兆ウォン1.70兆ウォン4.12兆ウォン1.38兆ウォン
Hyundai Motor10-2945.11兆ウォン2.68兆ウォン2.54兆ウォン2.85兆ウォン1.93兆ウォン
KB Financial Group11-1124.50兆ウォン2.37兆ウォン2.33兆ウォン2.71兆ウォン1.76兆ウォン
Shinhan Financial Group10-2718.64兆ウォン1.91兆ウォン1.95兆ウォン2.48兆ウォン1.61兆ウォン
Kia10-3031.60兆ウォン1.82兆ウォン1.46兆ウォン2.63兆ウォン1.29兆ウォン
Hana Financial Group10-2320.00兆ウォン1.63兆ウォン1.48兆ウォン1.59兆ウォン1.26兆ウォン
HD Korea Shipbuilding & Offshore Engineering10-288.29兆ウォン1.45兆ウォン1.05兆ウォン1.65兆ウォン7,770億ウォン
Woori Financial Group10-2313.30兆ウォン1.42兆ウォン9,880億ウォン1.32兆ウォン1.08兆ウォン
S-Oil11-0211.97兆ウォン1.41兆ウォン2,292億ウォン9,650億ウォン1.44兆ウォン
GS11-057.27兆ウォン1.27兆ウォン8,706億ウォン1.72兆ウォン6,804億ウォン
Samsung C&T10-2812.01兆ウォン1.14兆ウォン9,934億ウォン1.03兆ウォン8,009億ウォン
Industrial Bank OF Korea10-2610.47兆ウォン1.03兆ウォン9,767億ウォン9,151億ウォン7,712億ウォン

連結ベース · 発表値。

영업이익이 큰 순서로 15곳.

The 15 companies with the largest operating profit.

営業利益が大きい順に15社。

Source: DART, Financial Supervisory Service.
Limitations: 잠정실적은 회사가 발표한 값으로 외부감사인 검토 전이다 · 발표한 회사만의 합계라 지수 전체가 아니며, 회사가 더 발표하면 달라진다 · 연결 기준 공시만 더했다(별도 기준으로 발표한 회사 · 달러로 공시하는 회사 · 월별 실적만 공시하는 회사는 뺐다) · 지주회사의 연결 실적에는 상장 자회사의 이익이 겹쳐 들어간다 · 전년동기·전분기 값은 각 공시에 적힌 값이다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Limitations: Preliminary results are the figures announced by the companies, before review by external auditors · the sums cover only the companies that have announced, not the whole index, and change as more companies announce · only consolidated-basis announcements are added (companies announcing on a separate basis, companies reporting in dollars and companies announcing monthly results only are left out) · holding companies' consolidated results double-count the profits of listed subsidiaries · year-earlier and previous-quarter figures are the values stated in each announcement.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Limitations: 速報値(暫定決算)は企業が発表した値で、外部監査人のレビュー前である · 発表した企業だけの合計で指数全体ではなく、発表が増えれば変わる · 連結ベースの開示のみを合算した(個別ベースで発表した企業 · ドルで開示する企業 · 月次実績のみ開示する企業は除いた) · 持株会社の連結実績には上場子会社の利益が重複して入る · 前年同期・前四半期の値は各開示に記載された値である。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

표Table表Largest increases in operating profit from a year earlier

회사발표일매출영업이익전년 같은 분기전분기순이익
삼성전자10-29195.25조107.44조12.17조89.49조75.14조
SK하이닉스10-28104.62조83.33조11.38조60.54조39.78조
SK이노베이션10-2928.77조3.70조5,856억3.49조2.64조
HD현대10-2822.08조2.92조1.70조4.12조1.38조
S-Oil11-0211.97조1.41조2,292억9,650억1.44조
삼성SDI10-294.69조4,078억-5,913억2,038억3,422억
SK텔레콤11-044.50조5,523억484억5,660억4,118억
우리금융지주10-2313.30조1.42조9,880억1.32조1.08조
삼성전기10-283.76조6,910억2,603억4,404억4,850억
GS11-057.27조1.27조8,706억1.72조6,804억
CompanyAnnouncedRevenueOperating profitSame quarter a year earlierPrevious quarterNet profit
Samsung Electronics10-29KRW 195.25trnKRW 107.44trnKRW 12.17trnKRW 89.49trnKRW 75.14trn
SK hynix10-28KRW 104.62trnKRW 83.33trnKRW 11.38trnKRW 60.54trnKRW 39.78trn
SK Innovation10-29KRW 28.77trnKRW 3.70trn5,856 KRW 100mnKRW 3.49trnKRW 2.64trn
HD Hyundai10-28KRW 22.08trnKRW 2.92trnKRW 1.70trnKRW 4.12trnKRW 1.38trn
S-Oil11-02KRW 11.97trnKRW 1.41trn2,292 KRW 100mn9,650 KRW 100mnKRW 1.44trn
Samsung SDI10-29KRW 4.69trn4,078 KRW 100mn-5,913 KRW 100mn2,038 KRW 100mn3,422 KRW 100mn
SK Telecom11-04KRW 4.50trn5,523 KRW 100mn484 KRW 100mn5,660 KRW 100mn4,118 KRW 100mn
Woori Financial Group10-23KRW 13.30trnKRW 1.42trn9,880 KRW 100mnKRW 1.32trnKRW 1.08trn
Samsung Electro-Mechanics10-28KRW 3.76trn6,910 KRW 100mn2,603 KRW 100mn4,404 KRW 100mn4,850 KRW 100mn
GS11-05KRW 7.27trnKRW 1.27trn8,706 KRW 100mnKRW 1.72trn6,804 KRW 100mn
企業発表日売上高営業利益前年同期前四半期純利益
Samsung Electronics10-29195.25兆ウォン107.44兆ウォン12.17兆ウォン89.49兆ウォン75.14兆ウォン
SK hynix10-28104.62兆ウォン83.33兆ウォン11.38兆ウォン60.54兆ウォン39.78兆ウォン
SK Innovation10-2928.77兆ウォン3.70兆ウォン5,856億ウォン3.49兆ウォン2.64兆ウォン
HD Hyundai10-2822.08兆ウォン2.92兆ウォン1.70兆ウォン4.12兆ウォン1.38兆ウォン
S-Oil11-0211.97兆ウォン1.41兆ウォン2,292億ウォン9,650億ウォン1.44兆ウォン
Samsung SDI10-294.69兆ウォン4,078億ウォン-5,913億ウォン2,038億ウォン3,422億ウォン
SK Telecom11-044.50兆ウォン5,523億ウォン484億ウォン5,660億ウォン4,118億ウォン
Woori Financial Group10-2313.30兆ウォン1.42兆ウォン9,880億ウォン1.32兆ウォン1.08兆ウォン
Samsung Electro-Mechanics10-283.76兆ウォン6,910億ウォン2,603億ウォン4,404億ウォン4,850億ウォン
GS11-057.27兆ウォン1.27兆ウォン8,706億ウォン1.72兆ウォン6,804億ウォン

전년 같은 분기보다 영업이익이 가장 많이 늘어난 10곳(금액 기준).

The 10 companies whose operating profit rose most from a year earlier (by amount).

前年同期より営業利益が最も増えた10社(金額ベース)。

Source: DART, Financial Supervisory Service.
Limitations: 잠정실적은 회사가 발표한 값으로 외부감사인 검토 전이다 · 발표한 회사만의 합계라 지수 전체가 아니며, 회사가 더 발표하면 달라진다 · 연결 기준 공시만 더했다(별도 기준으로 발표한 회사 · 달러로 공시하는 회사 · 월별 실적만 공시하는 회사는 뺐다) · 지주회사의 연결 실적에는 상장 자회사의 이익이 겹쳐 들어간다 · 전년동기·전분기 값은 각 공시에 적힌 값이다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Limitations: Preliminary results are the figures announced by the companies, before review by external auditors · the sums cover only the companies that have announced, not the whole index, and change as more companies announce · only consolidated-basis announcements are added (companies announcing on a separate basis, companies reporting in dollars and companies announcing monthly results only are left out) · holding companies' consolidated results double-count the profits of listed subsidiaries · year-earlier and previous-quarter figures are the values stated in each announcement.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Limitations: 速報値(暫定決算)は企業が発表した値で、外部監査人のレビュー前である · 発表した企業だけの合計で指数全体ではなく、発表が増えれば変わる · 連結ベースの開示のみを合算した(個別ベースで発表した企業 · ドルで開示する企業 · 月次実績のみ開示する企業は除いた) · 持株会社の連結実績には上場子会社の利益が重複して入る · 前年同期・前四半期の値は各開示に記載された値である。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

표Table表Largest decreases in operating profit from a year earlier

회사발표일매출영업이익전년 같은 분기전분기순이익
한국금융지주11-0511.18조3,004억8,491억1.34조2,818억
한화에어로스페이스10-296.09조4,520억8,396억1.37조-367억
메리츠금융지주11-1113.13조5,199억8,623억9,676억4,905억
LG디스플레이10-226.28조2,506억4,310억-1,077억7,556억
롯데케미칼11-065.40조-2,814억-1,326억1,101억-2,898억
BNK금융지주10-263.10조2,395억3,804억2,357억2,171억
고려아연11-046.09조1,417억2,734억5,871억2,254억
크래프톤11-109,714억2,250억3,486억4,109억-684억
LG화학11-0515.50조5,612억6,797억5,996억-6,000억
LG이노텍10-276.37조948억2,037억2,458억952억
CompanyAnnouncedRevenueOperating profitSame quarter a year earlierPrevious quarterNet profit
Korea Investment Holdings11-05KRW 11.18trn3,004 KRW 100mn8,491 KRW 100mnKRW 1.34trn2,818 KRW 100mn
Hanwha Aerospace10-29KRW 6.09trn4,520 KRW 100mn8,396 KRW 100mnKRW 1.37trn-367 KRW 100mn
Meritz Financial Group11-11KRW 13.13trn5,199 KRW 100mn8,623 KRW 100mn9,676 KRW 100mn4,905 KRW 100mn
LG Display10-22KRW 6.28trn2,506 KRW 100mn4,310 KRW 100mn-1,077 KRW 100mn7,556 KRW 100mn
Lotte Chemical11-06KRW 5.40trn-2,814 KRW 100mn-1,326 KRW 100mn1,101 KRW 100mn-2,898 KRW 100mn
BNK Financial Group10-26KRW 3.10trn2,395 KRW 100mn3,804 KRW 100mn2,357 KRW 100mn2,171 KRW 100mn
Korea Zinc11-04KRW 6.09trn1,417 KRW 100mn2,734 KRW 100mn5,871 KRW 100mn2,254 KRW 100mn
Krafton11-109,714 KRW 100mn2,250 KRW 100mn3,486 KRW 100mn4,109 KRW 100mn-684 KRW 100mn
LG Chem11-05KRW 15.50trn5,612 KRW 100mn6,797 KRW 100mn5,996 KRW 100mn-6,000 KRW 100mn
LG Innotek10-27KRW 6.37trn948 KRW 100mn2,037 KRW 100mn2,458 KRW 100mn952 KRW 100mn
企業発表日売上高営業利益前年同期前四半期純利益
Korea Investment Holdings11-0511.18兆ウォン3,004億ウォン8,491億ウォン1.34兆ウォン2,818億ウォン
Hanwha Aerospace10-296.09兆ウォン4,520億ウォン8,396億ウォン1.37兆ウォン-367億ウォン
Meritz Financial Group11-1113.13兆ウォン5,199億ウォン8,623億ウォン9,676億ウォン4,905億ウォン
LG Display10-226.28兆ウォン2,506億ウォン4,310億ウォン-1,077億ウォン7,556億ウォン
Lotte Chemical11-065.40兆ウォン-2,814億ウォン-1,326億ウォン1,101億ウォン-2,898億ウォン
BNK Financial Group10-263.10兆ウォン2,395億ウォン3,804億ウォン2,357億ウォン2,171億ウォン
Korea Zinc11-046.09兆ウォン1,417億ウォン2,734億ウォン5,871億ウォン2,254億ウォン
Krafton11-109,714億ウォン2,250億ウォン3,486億ウォン4,109億ウォン-684億ウォン
LG Chem11-0515.50兆ウォン5,612億ウォン6,797億ウォン5,996億ウォン-6,000億ウォン
LG Innotek10-276.37兆ウォン948億ウォン2,037億ウォン2,458億ウォン952億ウォン

전년 같은 분기보다 영업이익이 가장 많이 줄어든 10곳(금액 기준).

The 10 companies whose operating profit fell most from a year earlier (by amount).

前年同期より営業利益が最も減った10社(金額ベース)。

Source: DART, Financial Supervisory Service.
Limitations: 잠정실적은 회사가 발표한 값으로 외부감사인 검토 전이다 · 발표한 회사만의 합계라 지수 전체가 아니며, 회사가 더 발표하면 달라진다 · 연결 기준 공시만 더했다(별도 기준으로 발표한 회사 · 달러로 공시하는 회사 · 월별 실적만 공시하는 회사는 뺐다) · 지주회사의 연결 실적에는 상장 자회사의 이익이 겹쳐 들어간다 · 전년동기·전분기 값은 각 공시에 적힌 값이다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Limitations: Preliminary results are the figures announced by the companies, before review by external auditors · the sums cover only the companies that have announced, not the whole index, and change as more companies announce · only consolidated-basis announcements are added (companies announcing on a separate basis, companies reporting in dollars and companies announcing monthly results only are left out) · holding companies' consolidated results double-count the profits of listed subsidiaries · year-earlier and previous-quarter figures are the values stated in each announcement.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Limitations: 速報値(暫定決算)は企業が発表した値で、外部監査人のレビュー前である · 発表した企業だけの合計で指数全体ではなく、発表が増えれば変わる · 連結ベースの開示のみを合算した(個別ベースで発表した企業 · ドルで開示する企業 · 月次実績のみ開示する企業は除いた) · 持株会社の連結実績には上場子会社の利益が重複して入る · 前年同期・前四半期の値は各開示に記載された値である。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

표Table表Companies whose operating profit changed sign from a year earlier

구분회사전년 같은 분기이번 분기
흑자 전환삼성SDI-5,913억4,078억
흑자 전환하이브-422억1,885억
흑자 전환엔씨소프트-75억1,196억
흑자 전환한화솔루션-74억905억
흑자 전환OCI홀딩스-533억680억
흑자 전환OCI-103억303억
적자 전환엘앤에프221억-265억
적자 전환금호석유844억-208억
적자 전환지역난방공사894억-79억
적자 지속롯데케미칼-1,326억-2,814억
적자 지속SKC-549억-496억
적자 지속SK아이이테크놀로지-472억-368억
적자 지속에코프로머티-251억-290억
적자 지속두산로보틱스-153억-134억
적자 지속SK바이오사이언스-194억-112억

영업이익 기준.

TypeCompanySame quarter a year earlierThis quarter
Turned to profitSamsung SDI-5,913 KRW 100mn4,078 KRW 100mn
Turned to profitHybe-422 KRW 100mn1,885 KRW 100mn
Turned to profitNC-75 KRW 100mn1,196 KRW 100mn
Turned to profitHanwha Solutions-74 KRW 100mn905 KRW 100mn
Turned to profitOCI Holdings-533 KRW 100mn680 KRW 100mn
Turned to profitOCI-103 KRW 100mn303 KRW 100mn
Turned to lossL&F221 KRW 100mn-265 KRW 100mn
Turned to lossKumho Petro Chemical844 KRW 100mn-208 KRW 100mn
Turned to lossKorea District Heating894 KRW 100mn-79 KRW 100mn
Still loss-makingLotte Chemical-1,326 KRW 100mn-2,814 KRW 100mn
Still loss-makingSKC-549 KRW 100mn-496 KRW 100mn
Still loss-makingSK ie technology-472 KRW 100mn-368 KRW 100mn
Still loss-makingEcopro Materials-251 KRW 100mn-290 KRW 100mn
Still loss-makingDoosan Robotics-153 KRW 100mn-134 KRW 100mn
Still loss-makingSK Bioscience-194 KRW 100mn-112 KRW 100mn

Operating profit basis.

区分企業前年同期今四半期
黒字転換Samsung SDI-5,913億ウォン4,078億ウォン
黒字転換Hybe-422億ウォン1,885億ウォン
黒字転換NC-75億ウォン1,196億ウォン
黒字転換Hanwha Solutions-74億ウォン905億ウォン
黒字転換OCI Holdings-533億ウォン680億ウォン
黒字転換OCI-103億ウォン303億ウォン
赤字転落L&F221億ウォン-265億ウォン
赤字転落Kumho Petro Chemical844億ウォン-208億ウォン
赤字転落Korea District Heating894億ウォン-79億ウォン
赤字継続Lotte Chemical-1,326億ウォン-2,814億ウォン
赤字継続SKC-549億ウォン-496億ウォン
赤字継続SK ie technology-472億ウォン-368億ウォン
赤字継続Ecopro Materials-251億ウォン-290億ウォン
赤字継続Doosan Robotics-153億ウォン-134億ウォン
赤字継続SK Bioscience-194億ウォン-112億ウォン

営業利益ベース。

흑자 전환 6곳 · 적자 전환 3곳 · 적자 지속 6곳.

Turned to a profit: 6 · turned to a loss: 3 · still loss-making: 6.

黒字転換6社 · 赤字転落3社 · 赤字継続6社。

Source: DART, Financial Supervisory Service.
Limitations: 잠정실적은 회사가 발표한 값으로 외부감사인 검토 전이다 · 발표한 회사만의 합계라 지수 전체가 아니며, 회사가 더 발표하면 달라진다 · 연결 기준 공시만 더했다(별도 기준으로 발표한 회사 · 달러로 공시하는 회사 · 월별 실적만 공시하는 회사는 뺐다) · 지주회사의 연결 실적에는 상장 자회사의 이익이 겹쳐 들어간다 · 전년동기·전분기 값은 각 공시에 적힌 값이다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Limitations: Preliminary results are the figures announced by the companies, before review by external auditors · the sums cover only the companies that have announced, not the whole index, and change as more companies announce · only consolidated-basis announcements are added (companies announcing on a separate basis, companies reporting in dollars and companies announcing monthly results only are left out) · holding companies' consolidated results double-count the profits of listed subsidiaries · year-earlier and previous-quarter figures are the values stated in each announcement.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Limitations: 速報値(暫定決算)は企業が発表した値で、外部監査人のレビュー前である · 発表した企業だけの合計で指数全体ではなく、発表が増えれば変わる · 連結ベースの開示のみを合算した(個別ベースで発表した企業 · ドルで開示する企業 · 月次実績のみ開示する企業は除いた) · 持株会社の連結実績には上場子会社の利益が重複して入る · 前年同期・前四半期の値は各開示に記載された値である。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

표Table表Companies that announced but are left out of the sums

회사발표일이유
대웅제약11-04별도 기준 공시(또는 공시 통화가 다름)
대한항공10-15별도 기준 공시(또는 공시 통화가 다름)
두산밥캣10-29별도 기준 공시(또는 공시 통화가 다름)
오리온11-11월별 실적만 공시
유한양행10-28별도 기준 공시(또는 공시 통화가 다름)
한국가스공사11-11월별 실적만 공시

별도 기준 공시는 연결 기준 합계와 섞지 않는다.

CompanyAnnouncedReason
Daewoong Pharma11-04Separate (parent-only) basis, or a different reporting currency
Korean Air Lines10-15Separate (parent-only) basis, or a different reporting currency
Doosan Bobcat10-29Separate (parent-only) basis, or a different reporting currency
Orion11-11Monthly results only
Yuhan10-28Separate (parent-only) basis, or a different reporting currency
KoreaGasCorporation11-11Monthly results only

Separate-basis announcements are not mixed into the consolidated sums.

企業発表日理由
Daewoong Pharma11-04個別ベースの開示(または開示通貨が異なる)
Korean Air Lines10-15個別ベースの開示(または開示通貨が異なる)
Doosan Bobcat10-29個別ベースの開示(または開示通貨が異なる)
Orion11-11月次実績のみ開示
Yuhan10-28個別ベースの開示(または開示通貨が異なる)
KoreaGasCorporation11-11月次実績のみ開示

個別ベースの開示は連結ベースの合計と混ぜない。

발표는 했지만 합계에서 뺀 6곳과 그 이유.

The 6 companies that announced but are left out of the sums, and why.

発表はしたが合計から除いた6社とその理由。

Source: DART, Financial Supervisory Service.
Limitations: 잠정실적은 회사가 발표한 값으로 외부감사인 검토 전이다 · 발표한 회사만의 합계라 지수 전체가 아니며, 회사가 더 발표하면 달라진다 · 연결 기준 공시만 더했다(별도 기준으로 발표한 회사 · 달러로 공시하는 회사 · 월별 실적만 공시하는 회사는 뺐다) · 지주회사의 연결 실적에는 상장 자회사의 이익이 겹쳐 들어간다 · 전년동기·전분기 값은 각 공시에 적힌 값이다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Limitations: Preliminary results are the figures announced by the companies, before review by external auditors · the sums cover only the companies that have announced, not the whole index, and change as more companies announce · only consolidated-basis announcements are added (companies announcing on a separate basis, companies reporting in dollars and companies announcing monthly results only are left out) · holding companies' consolidated results double-count the profits of listed subsidiaries · year-earlier and previous-quarter figures are the values stated in each announcement.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Limitations: 速報値(暫定決算)は企業が発表した値で、外部監査人のレビュー前である · 発表した企業だけの合計で指数全体ではなく、発表が増えれば変わる · 連結ベースの開示のみを合算した(個別ベースで発表した企業 · ドルで開示する企業 · 月次実績のみ開示する企業は除いた) · 持株会社の連結実績には上場子会社の利益が重複して入る · 前年同期・前四半期の値は各開示に記載された値である。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

표Table表Preliminary versus filed figures for companies whose quarterly report has arrived

회사영업이익(발표)영업이익(보고서)차이순이익(발표)순이익(보고서)
HD현대2.92조2,120억-27,077억1.38조1,989억
SK이노베이션3.70조1.75조-19,541억2.64조1.85조
GS1.27조305억-12,443억6,804억216억
삼성물산1.14조2,837억-8,591억8,009억4,911억
두산4,594억1,683억-2,911억1,031억510억
DL1,740억5억-1,735억1,650억-88억
카카오2,403억1,178억-1,225억1,777억1,004억
한국앤컴퍼니665억321억-344억465억153억
동원시스템즈240억154억-86억53억-34억
POSCO홀딩스9,400억9,447억+47억3,800억3,798억
신한지주1.91조1.91조+28억1.61조1.61조
세아제강지주933억905억-28억68억45억
종근당237억220억-16억188억193억
삼성중공업3,384억3,383억-1억4,708억4,708억
넷마블504억503억-1억222억222억

보고서 값 = 분기보고서 연결 재무제표의 3개월 값.

CompanyOperating profit (announced)Operating profit (report)DifferenceNet profit (announced)Net profit (report)
HD HyundaiKRW 2.92trn2,120 KRW 100mn-27,077 KRW 100mnKRW 1.38trn1,989 KRW 100mn
SK InnovationKRW 3.70trnKRW 1.75trn-19,541 KRW 100mnKRW 2.64trnKRW 1.85trn
GSKRW 1.27trn305 KRW 100mn-12,443 KRW 100mn6,804 KRW 100mn216 KRW 100mn
Samsung C&TKRW 1.14trn2,837 KRW 100mn-8,591 KRW 100mn8,009 KRW 100mn4,911 KRW 100mn
Doosan4,594 KRW 100mn1,683 KRW 100mn-2,911 KRW 100mn1,031 KRW 100mn510 KRW 100mn
DL1,740 KRW 100mn5 KRW 100mn-1,735 KRW 100mn1,650 KRW 100mn-88 KRW 100mn
Kakao2,403 KRW 100mn1,178 KRW 100mn-1,225 KRW 100mn1,777 KRW 100mn1,004 KRW 100mn
Hankook & Company665 KRW 100mn321 KRW 100mn-344 KRW 100mn465 KRW 100mn153 KRW 100mn
Dongwon Systems240 KRW 100mn154 KRW 100mn-86 KRW 100mn53 KRW 100mn-34 KRW 100mn
POSCO Holdings9,400 KRW 100mn9,447 KRW 100mn+47 KRW 100mn3,800 KRW 100mn3,798 KRW 100mn
Shinhan Financial GroupKRW 1.91trnKRW 1.91trn+28 KRW 100mnKRW 1.61trnKRW 1.61trn
SeAH Steel Holdings933 KRW 100mn905 KRW 100mn-28 KRW 100mn68 KRW 100mn45 KRW 100mn
Chong Kun Dang Pharmaceutical237 KRW 100mn220 KRW 100mn-16 KRW 100mn188 KRW 100mn193 KRW 100mn
Samsung Heavy Industries3,384 KRW 100mn3,383 KRW 100mn-1 KRW 100mn4,708 KRW 100mn4,708 KRW 100mn
Netmarble504 KRW 100mn503 KRW 100mn-1 KRW 100mn222 KRW 100mn222 KRW 100mn

Report value = the three-month figure in the consolidated financial statements of the quarterly report.

企業営業利益(発表)営業利益(報告書)差純利益(発表)純利益(報告書)
HD Hyundai2.92兆ウォン2,120億ウォン-27,077億ウォン1.38兆ウォン1,989億ウォン
SK Innovation3.70兆ウォン1.75兆ウォン-19,541億ウォン2.64兆ウォン1.85兆ウォン
GS1.27兆ウォン305億ウォン-12,443億ウォン6,804億ウォン216億ウォン
Samsung C&T1.14兆ウォン2,837億ウォン-8,591億ウォン8,009億ウォン4,911億ウォン
Doosan4,594億ウォン1,683億ウォン-2,911億ウォン1,031億ウォン510億ウォン
DL1,740億ウォン5億ウォン-1,735億ウォン1,650億ウォン-88億ウォン
Kakao2,403億ウォン1,178億ウォン-1,225億ウォン1,777億ウォン1,004億ウォン
Hankook & Company665億ウォン321億ウォン-344億ウォン465億ウォン153億ウォン
Dongwon Systems240億ウォン154億ウォン-86億ウォン53億ウォン-34億ウォン
POSCO Holdings9,400億ウォン9,447億ウォン+47億ウォン3,800億ウォン3,798億ウォン
Shinhan Financial Group1.91兆ウォン1.91兆ウォン+28億ウォン1.61兆ウォン1.61兆ウォン
SeAH Steel Holdings933億ウォン905億ウォン-28億ウォン68億ウォン45億ウォン
Chong Kun Dang Pharmaceutical237億ウォン220億ウォン-16億ウォン188億ウォン193億ウォン
Samsung Heavy Industries3,384億ウォン3,383億ウォン-1億ウォン4,708億ウォン4,708億ウォン
Netmarble504億ウォン503億ウォン-1億ウォン222億ウォン222億ウォン

報告書の値 = 四半期報告書の連結財務諸表の3か月の値。

분기보고서가 들어온 150곳의 발표값과 보고서 값 — 차이가 큰 순서로 15곳. 영업이익이 1억 넘게 달라진 곳 13곳.

Announced and filed figures for the 150 companies whose quarterly report has arrived — the 15 with the largest differences. Companies whose operating profit differs by more than KRW 100mn: 13.

四半期報告書が届いた150社の発表値と報告書の値 — 差が大きい順に15社。営業利益が1億ウォン超異なる企業13社。

Source: DART, Financial Supervisory Service.
Limitations: 잠정실적은 회사가 발표한 값으로 외부감사인 검토 전이다 · 발표한 회사만의 합계라 지수 전체가 아니며, 회사가 더 발표하면 달라진다 · 연결 기준 공시만 더했다(별도 기준으로 발표한 회사 · 달러로 공시하는 회사 · 월별 실적만 공시하는 회사는 뺐다) · 지주회사의 연결 실적에는 상장 자회사의 이익이 겹쳐 들어간다 · 전년동기·전분기 값은 각 공시에 적힌 값이다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Limitations: Preliminary results are the figures announced by the companies, before review by external auditors · the sums cover only the companies that have announced, not the whole index, and change as more companies announce · only consolidated-basis announcements are added (companies announcing on a separate basis, companies reporting in dollars and companies announcing monthly results only are left out) · holding companies' consolidated results double-count the profits of listed subsidiaries · year-earlier and previous-quarter figures are the values stated in each announcement.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

Source: DART, Financial Supervisory Service.
Limitations: 速報値(暫定決算)は企業が発表した値で、外部監査人のレビュー前である · 発表した企業だけの合計で指数全体ではなく、発表が増えれば変わる · 連結ベースの開示のみを合算した(個別ベースで発表した企業 · ドルで開示する企業 · 月次実績のみ開示する企業は除いた) · 持株会社の連結実績には上場子会社の利益が重複して入る · 前年同期・前四半期の値は各開示に記載された値である。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

∞

천장 — 이 페이지가 말할 수 없는 것Ceilings — what this page cannot say限界 — このページが言えないこと

  • 발표값이다. 외부감사인 검토 전이고, 분기보고서에서 달라질 수 있다.
  • 발표한 회사만의 합계다. 아직 발표하지 않은 회사가 들어오면 합계와 증감률이 달라진다.
  • 지주회사는 겹친다. 연결 실적에 상장 자회사의 이익이 들어 있어 합계가 부풀려진다 — 지주회사를 뺀 값을 같이 본다.
  • 별도 기준 · 달러 공시 · 월별 공시 회사는 합계에 없다.
  • P/B 밴드는 같은 회사들만의 것이다. 2013년부터 자료가 있는 회사만 더했고 금융회사는 없다. 연말 값이라 연중 고점과 저점은 잡히지 않는다.
  • P/B 와 P/E 의 차이는 ROE 다. 이익이 평소보다 많을 때 P/E 는 낮아 보인다 — 그래서 기준을 P/B 에 둔다.
  • These are announced figures. They are before review by external auditors and may change in the quarterly reports.
  • The sums cover only the companies that have announced. The sums and growth rates change as the companies yet to announce come in.
  • Holding companies overlap. Their consolidated results include the profits of listed subsidiaries, which inflates the sums — the values excluding holding companies are shown alongside.
  • Companies announcing on a separate basis, in dollars or monthly are not in the sums.
  • The P/B band covers the same companies only. Only companies with data since 2013 are added, and there are no financial companies. These are year-end values, so intra-year highs and lows are not captured.
  • The gap between P/B and P/E is ROE. When earnings are above their usual level, P/E looks low — which is why P/B is used as the yardstick.
  • 発表値である。外部監査人のレビュー前で、四半期報告書で変わり得る。
  • 発表した企業だけの合計である。まだ発表していない企業が加わると合計と増減率が変わる。
  • 持株会社は重複する。連結実績に上場子会社の利益が入っているため合計が膨らむ — 持株会社を除いた値を併せて見る。
  • 個別ベース · ドル建て開示 · 月次開示の企業は合計に含まれない。
  • PBRバンドは同じ企業だけのものである。2013年からデータがある企業だけを合算し、金融会社は含まない。年末の値のため年中の高値と安値は捉えられない。
  • PBRとPERの差はROEである。利益が平常より多いときPERは低く見える — そのため基準をPBRに置く。

Source: DART, Financial Supervisory Service. Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.